Johnson & Johnson vaccine J&J
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. Image Credit: Reuters

Washington: The US Food and Drug Administration on Monday updated its warning labels for the Johnson & Johnson COVID-19 vaccine to include information about an observed “increased risk” of a rare neurological disorder.

Based on analysis of a federal vaccine safety monitoring system, officials have identified 100 preliminary reports of Guillain-Barre Syndrome after approximately 12.5 million doses administered, people familiar with the matter said.

Of these reports, 95 of them were serious and required hospitalization. There was one reported death.